시장조사 보고서 : 세계의 블로킹 펩타이드 시장예측 2021년-2026년

■ 영문 제목 : Global Blocking Peptides Market Growth 2021-2026
	■ 상품코드 : LPI-2108K202167 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 8월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 95 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료장치

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦5,124,000	견적의뢰/주문/질문
Multi User (20명 열람용)	USD5,490 ⇒환산￦7,686,000	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦10,248,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 블로킹 펩타이드의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (SSX2 블로킹 펩타이드, KLK2 블로킹 펩타이드, FZD4 블로킹 펩타이드, SPDEF 블로킹 펩타이드, 기타)와 용도별 시장규모 (면역 요법, 화학 분석, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 블로킹 펩타이드 시장 점유율
- 지역별 블로킹 펩타이드 시장규모
- 주요지역의 종류별 시장규모 (SSX2 블로킹 펩타이드, KLK2 블로킹 펩타이드, FZD4 블로킹 펩타이드, SPDEF 블로킹 펩타이드, 기타)
- 주요지역의 용도별 시장규모 (면역 요법, 화학 분석, 기타)
- 미주의 블로킹 펩타이드 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 블로킹 펩타이드 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 블로킹 펩타이드 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 블로킹 펩타이드 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 블로킹 펩타이드 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Blocking Peptides will have significant change from previous year. By the most conservative estimates of global Blocking Peptides market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Blocking Peptides market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Blocking Peptides market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
SSX2 Blocking Peptide
KLK2 Blocking Peptide
FZD4 Blocking Peptide
SPDEF Blocking Peptide
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Immunity Therapy
Chemical Analysis
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
amsbio
Abcam
Fitzgerald Industries International
Aviva Systems Biology
Alomone Labs
Merck
Abcepta

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Blocking Peptides Consumption 2016-2026
2.1.2 Blocking Peptides Consumption CAGR by Region
2.2 Blocking Peptides Segment by Type
2.2.1 SSX2 Blocking Peptide
2.2.2 KLK2 Blocking Peptide
2.2.3 FZD4 Blocking Peptide
2.2.4 SPDEF Blocking Peptide
2.2.5 Others
2.3 Blocking Peptides Sales by Type
2.3.1 Global Blocking Peptides Sales Market Share by Type (2016-2021)
2.3.2 Global Blocking Peptides Revenue and Market Share by Type (2016-2021)
2.3.3 Global Blocking Peptides Sale Price by Type (2016-2021)
2.4 Blocking Peptides Segment by Application
2.4.1 Immunity Therapy
2.4.2 Chemical Analysis
2.4.3 Others
2.5 Blocking Peptides Sales by Application
2.5.1 Global Blocking Peptides Sale Market Share by Application (2016-2021)
2.5.2 Global Blocking Peptides Revenue and Market Share by Application (2016-2021)
2.5.3 Global Blocking Peptides Sale Price by Application (2016-2021)

3 Global Blocking Peptides by Company
3.1 Global Blocking Peptides Sales Market Share by Company
3.1.1 Global Blocking Peptides Sales by Company (2019-2021)
3.1.2 Global Blocking Peptides Sales Market Share by Company (2019-2021)
3.2 Global Blocking Peptides Revenue Market Share by Company
3.2.1 Global Blocking Peptides Revenue by Company (2019-2021)
3.2.2 Global Blocking Peptides Revenue Market Share by Company (2019-2021)
3.3 Global Blocking Peptides Sale Price by Company
3.4 Global Manufacturers Blocking Peptides Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Blocking Peptides Product Location Distribution
3.4.2 Players Blocking Peptides Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Blocking Peptides by Region
4.1 Global Blocking Peptides by Region
4.1.1 Global Blocking Peptides Sales by Region
4.1.2 Global Blocking Peptides Revenue by Region
4.2 Americas Blocking Peptides Sales Growth
4.3 APAC Blocking Peptides Sales Growth
4.4 Europe Blocking Peptides Sales Growth
4.5 Middle East & Africa Blocking Peptides Sales Growth

5 Americas
5.1 Americas Blocking Peptides Sales by Country
5.1.1 Americas Blocking Peptides Sales by Country (2016-2021)
5.1.2 Americas Blocking Peptides Revenue by Country (2016-2021)
5.2 Americas Blocking Peptides Sales by Type
5.3 Americas Blocking Peptides Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Blocking Peptides Sales by Region
6.1.1 APAC Blocking Peptides Sales by Region (2016-2021)
6.1.2 APAC Blocking Peptides Revenue by Region (2016-2021)
6.2 APAC Blocking Peptides Sales by Type
6.3 APAC Blocking Peptides Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Blocking Peptides by Country
7.1.1 Europe Blocking Peptides Sales by Country (2016-2021)
7.1.2 Europe Blocking Peptides Revenue by Country (2016-2021)
7.2 Europe Blocking Peptides Sales by Type
7.3 Europe Blocking Peptides Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Blocking Peptides by Country
8.1.1 Middle East & Africa Blocking Peptides Sales by Country (2016-2021)
8.1.2 Middle East & Africa Blocking Peptides Revenue by Country (2016-2021)
8.2 Middle East & Africa Blocking Peptides Sales by Type
8.3 Middle East & Africa Blocking Peptides Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Blocking Peptides Distributors
10.3 Blocking Peptides Customer

11 Global Blocking Peptides Market Forecast
11.1 Global Blocking Peptides Forecast by Region
11.1.1 Global Blocking Peptides Forecast by Regions (2021-2026)
11.2.2 Global Blocking Peptides Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Blocking Peptides Forecast by Type
11.7 Global Blocking Peptides Forecast by Application

12 Key Players Analysis
12.1 amsbio
12.1.1 amsbio Company Information
12.1.2 amsbio Blocking Peptides Product Offered
12.1.3 amsbio Blocking Peptides Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 amsbio Main Business Overview
12.1.5 amsbio Latest Developments
12.2 Abcam
12.2.1 Abcam Company Information
12.2.2 Abcam Blocking Peptides Product Offered
12.2.3 Abcam Blocking Peptides Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Abcam Main Business Overview
12.2.5 Abcam Latest Developments
12.3 Fitzgerald Industries International
12.3.1 Fitzgerald Industries International Company Information
12.3.2 Fitzgerald Industries International Blocking Peptides Product Offered
12.3.3 Fitzgerald Industries International Blocking Peptides Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Fitzgerald Industries International Main Business Overview
12.3.5 Fitzgerald Industries International Latest Developments
12.4 Aviva Systems Biology
12.4.1 Aviva Systems Biology Company Information
12.4.2 Aviva Systems Biology Blocking Peptides Product Offered
12.4.3 Aviva Systems Biology Blocking Peptides Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Aviva Systems Biology Main Business Overview
12.4.5 Aviva Systems Biology Latest Developments
12.5 Alomone Labs
12.5.1 Alomone Labs Company Information
12.5.2 Alomone Labs Blocking Peptides Product Offered
12.5.3 Alomone Labs Blocking Peptides Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Alomone Labs Main Business Overview
12.5.5 Alomone Labs Latest Developments
12.6 Merck
12.6.1 Merck Company Information
12.6.2 Merck Blocking Peptides Product Offered
12.6.3 Merck Blocking Peptides Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Merck Main Business Overview
12.6.5 Merck Latest Developments
12.7 Abcepta
12.7.1 Abcepta Company Information
12.7.2 Abcepta Blocking Peptides Product Offered
12.7.3 Abcepta Blocking Peptides Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Abcepta Main Business Overview
12.7.5 Abcepta Latest Developments
…

13 Research Findings and Conclusion

List of Tables
Table 1. Blocking Peptides Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of SSX2 Blocking Peptide
Table 3. Major Players of KLK2 Blocking Peptide
Table 4. Major Players of FZD4 Blocking Peptide
Table 5. Major Players of SPDEF Blocking Peptide
Table 6. Major Players of Others
Table 7. Global Blocking Peptides Sales by Type (2016-2021) & (K Units)
Table 8. Global Blocking Peptides Sales Market Share by Type (2016-2021)
Table 9. Global Blocking Peptides Revenue by Type (2016-2021) & ($ million)
Table 10. Global Blocking Peptides Revenue Market Share by Type (2016-2021)
Table 11. Global Blocking Peptides Sale Price by Type (2016-2021)
Table 12. Global Blocking Peptides Sales by Application (2016-2021) & (K Units)
Table 13. Global Blocking Peptides Sales Market Share by Application (2016-2021)
Table 14. Global Blocking Peptides Value by Application (2016-2021)
Table 15. Global Blocking Peptides Revenue Market Share by Application (2016-2021)
Table 16. Global Blocking Peptides Sale Price by Application (2016-2021)
Table 17. Global Blocking Peptides Sales by Company (2019-2021) & (K Units)
Table 18. Global Blocking Peptides Sales Market Share by Company (2019-2021)
Table 19. Global Blocking Peptides Revenue by Company (2019-2021) ($ Millions)
Table 20. Global Blocking Peptides Revenue Market Share by Company (2019-2021)
Table 21. Global Blocking Peptides Sale Price by Company (2019-2021)
Table 22. Key Manufacturers Blocking Peptides Producing Area Distribution and Sales Area
Table 23. Players Blocking Peptides Products Offered
Table 24. Blocking Peptides Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Blocking Peptides Sales by Region (2016-2021) (K Units)
Table 28. Global Blocking Peptides Sales Market Share by Region (2016-2021)
Table 29. Global Blocking Peptides Revenue by Region (2016-2021) & ($ Millions)
Table 30. Global Blocking Peptides Revenue Market Share by Region (2016-2021)
Table 31. Americas Blocking Peptides Sales by Country (2016-2021) & (K Units)
Table 32. Americas Blocking Peptides Sales Market Share by Country (2016-2021)
Table 33. Americas Blocking Peptides Revenue by Country (2016-2021) & ($ Millions)
Table 34. Americas Blocking Peptides Revenue Market Share by Country (2016-2021)
Table 35. Americas Blocking Peptides Sales by Type (2016-2021) & (K Units)
Table 36. Americas Blocking Peptides Sales Market Share by Type (2016-2021)
Table 37. Americas Blocking Peptides Sales by Application (2016-2021) & (K Units)
Table 38. Americas Blocking Peptides Sales Market Share by Application (2016-2021)
Table 39. APAC Blocking Peptides Sales by Region (2016-2021) & (K Units)
Table 40. APAC Blocking Peptides Sales Market Share by Region (2016-2021)
Table 41. APAC Blocking Peptides Revenue by Region (2016-2021) & ($ Millions)
Table 42. APAC Blocking Peptides Revenue Market Share by Region (2016-2021)
Table 43. APAC Blocking Peptides Sales by Type (2016-2021) & (K Units)
Table 44. APAC Blocking Peptides Sales Market Share by Type (2016-2021)
Table 45. APAC Blocking Peptides Sales by Application (2016-2021) & (K Units)
Table 46. APAC Blocking Peptides Sales Market Share by Application (2016-2021)
Table 47. Europe Blocking Peptides Sales by Country (2016-2021) & (K Units)
Table 48. Europe Blocking Peptides Sales Market Share by Country (2016-2021)
Table 49. Europe Blocking Peptides Revenue by Country (2016-2021) & ($ Millions)
Table 50. Europe Blocking Peptides Revenue Market Share by Country (2016-2021)
Table 51. Europe Blocking Peptides Sales by Type (2016-2021) & (K Units)
Table 52. Europe Blocking Peptides Sales Market Share by Type (2016-2021)
Table 53. Europe Blocking Peptides Sales by Application (2016-2021) & (K Units)
Table 54. Europe Blocking Peptides Sales Market Share by Application (2016-2021)
Table 55. Middle East & Africa Blocking Peptides Sales by Country (2016-2021) & (K Units)
Table 56. Middle East & Africa Blocking Peptides Sales Market Share by Country (2016-2021)
Table 57. Middle East & Africa Blocking Peptides Revenue by Country (2016-2021) & ($ Millions)
Table 58. Middle East & Africa Blocking Peptides Revenue Market Share by Country (2016-2021)
Table 59. Middle East & Africa Blocking Peptides Sales by Type (2016-2021) & (K Units)
Table 60. Middle East & Africa Blocking Peptides Sales Market Share by Type (2016-2021)
Table 61. Middle East & Africa Blocking Peptides Sales by Application (2016-2021) & (K Units)
Table 62. Middle East & Africa Blocking Peptides Sales Market Share by Application (2016-2021)
Table 63. Key and Potential Regions of Blocking Peptides
Table 64. Key Application and Potential Industries of Blocking Peptides
Table 65. Key Challenges of Blocking Peptides
Table 66. Key Trends of Blocking Peptides
Table 67. Blocking Peptides Distributors List
Table 68. Blocking Peptides Customer List
Table 69. Global Blocking Peptides Sales Forecast by Region (2021-2026) & (K Units)
Table 70. Global Blocking Peptides Consumption Market Forecast by Region
Table 71. Global Blocking Peptides Revenue Forecast by Region (2021-2026) & ($ millions)
Table 72. Global Blocking Peptides Revenue Market Share Forecast by Region (2021-2026)
Table 73. Americas Blocking Peptides Sales Forecast by Country (2021-2026) & (K Units)
Table 74. Americas Blocking Peptides Revenue Forecast by Country (2021-2026) & ($ millions)
Table 75. APAC Blocking Peptides Sales Forecast by Region (2021-2026) & (K Units)
Table 76. APAC Blocking Peptides Revenue Forecast by Region (2021-2026) & ($ millions)
Table 77. Europe Blocking Peptides Sales Forecast by Country (2021-2026) & (K Units)
Table 78. Europe Blocking Peptides Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Middle East & Africa Blocking Peptides Sales Forecast by Country (2021-2026) & (K Units)
Table 80. Middle East & Africa Blocking Peptides Revenue Forecast by Country (2021-2026) & ($ millions)
Table 81. Global Blocking Peptides Sales Forecast by Type (2021-2026) & (K Units)
Table 82. Global Blocking Peptides Sales Market Share Forecast by Type (2021-2026)
Table 83. Global Blocking Peptides Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 84. Global Blocking Peptides Revenue Market Share Forecast by Type (2021-2026)
Table 85. Global Blocking Peptides Sales Forecast by Application (2021-2026) & (K Units)
Table 86. Global Blocking Peptides Sales Market Share Forecast by Application (2021-2026)
Table 87. Global Blocking Peptides Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 88. Global Blocking Peptides Revenue Market Share Forecast by Application (2021-2026)
Table 89. amsbio Basic Information, Blocking Peptides Manufacturing Base, Sales Area and Its Competitors
Table 90. amsbio Blocking Peptides Product Offered
Table 91. amsbio Blocking Peptides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 92. amsbio Main Business
Table 93. amsbio Latest Developments
Table 94. Abcam Basic Information, Blocking Peptides Manufacturing Base, Sales Area and Its Competitors
Table 95. Abcam Blocking Peptides Product Offered
Table 96. Abcam Blocking Peptides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 97. Abcam Main Business
Table 98. Abcam Latest Developments
Table 99. Fitzgerald Industries International Basic Information, Blocking Peptides Manufacturing Base, Sales Area and Its Competitors
Table 100. Fitzgerald Industries International Blocking Peptides Product Offered
Table 101. Fitzgerald Industries International Blocking Peptides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 102. Fitzgerald Industries International Main Business
Table 103. Fitzgerald Industries International Latest Developments
Table 104. Aviva Systems Biology Basic Information, Blocking Peptides Manufacturing Base, Sales Area and Its Competitors
Table 105. Aviva Systems Biology Blocking Peptides Product Offered
Table 106. Aviva Systems Biology Blocking Peptides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 107. Aviva Systems Biology Main Business
Table 108. Aviva Systems Biology Latest Developments
Table 109. Alomone Labs Basic Information, Blocking Peptides Manufacturing Base, Sales Area and Its Competitors
Table 110. Alomone Labs Blocking Peptides Product Offered
Table 111. Alomone Labs Blocking Peptides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 112. Alomone Labs Main Business
Table 113. Alomone Labs Latest Developments
Table 114. Merck Basic Information, Blocking Peptides Manufacturing Base, Sales Area and Its Competitors
Table 115. Merck Blocking Peptides Product Offered
Table 116. Merck Blocking Peptides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 117. Merck Main Business
Table 118. Merck Latest Developments
Table 119. Abcepta Basic Information, Blocking Peptides Manufacturing Base, Sales Area and Its Competitors
Table 120. Abcepta Blocking Peptides Product Offered
Table 121. Abcepta Blocking Peptides Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 122. Abcepta Main Business
Table 123. Abcepta Latest Developments
List of Figures
Figure 1. Picture of Blocking Peptides
Figure 2. Blocking Peptides Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Blocking Peptides Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Blocking Peptides Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Blocking Peptides Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of SSX2 Blocking Peptide
Figure 10. Product Picture of KLK2 Blocking Peptide
Figure 11. Product Picture of FZD4 Blocking Peptide
Figure 12. Product Picture of SPDEF Blocking Peptide
Figure 13. Product Picture of Others
Figure 14. Global Blocking Peptides Sales Market Share by Type in 2020
Figure 15. Global Blocking Peptides Revenue Market Share by Type (2016-2021)
Figure 16. Blocking Peptides Consumed in Immunity Therapy
Figure 17. Global Blocking Peptides Market: Immunity Therapy (2016-2021) & (K Units)
Figure 18. Blocking Peptides Consumed in Chemical Analysis
Figure 19. Global Blocking Peptides Market: Chemical Analysis (2016-2021) & (K Units)
Figure 20. Blocking Peptides Consumed in Others
Figure 21. Global Blocking Peptides Market: Others (2016-2021) & (K Units)
Figure 22. Global Blocking Peptides Sales Market Share by Application (2016-2021)
Figure 23. Global Blocking Peptides Revenue Market Share by Application in 2020
Figure 24. Blocking Peptides Revenue Market by Company in 2020 ($ Million)
Figure 25. Global Blocking Peptides Revenue Market Share by Company in 2020
Figure 26. Global Blocking Peptides Sales Market Share by Regions (2016-2021)
Figure 27. Global Blocking Peptides Revenue Market Share by Region in 2020
Figure 28. Americas Blocking Peptides Sales 2016-2021 (K Units)
Figure 29. Americas Blocking Peptides Revenue 2016-2021 ($ Millions)
Figure 30. APAC Blocking Peptides Sales 2016-2021 (K Units)
Figure 31. APAC Blocking Peptides Revenue 2016-2021 ($ Millions)
Figure 32. Europe Blocking Peptides Sales 2016-2021 (K Units)
Figure 33. Europe Blocking Peptides Revenue 2016-2021 ($ Millions)
Figure 34. Middle East & Africa Blocking Peptides Sales 2016-2021 (K Units)
Figure 35. Middle East & Africa Blocking Peptides Revenue 2016-2021 ($ Millions)
Figure 36. Americas Blocking Peptides Sales Market Share by Country in 2020
Figure 37. Americas Blocking Peptides Revenue Market Share by Country in 2020
Figure 38. Americas Blocking Peptides Sales Market Share by Type in 2020
Figure 39. Americas Blocking Peptides Sales Market Share by Application in 2020
Figure 40. United States Blocking Peptides Revenue Growth 2016-2021 ($ Millions)
Figure 41. Canada Blocking Peptides Revenue Growth 2016-2021 ($ Millions)
Figure 42. Mexico Blocking Peptides Revenue Growth 2016-2021 ($ Millions)
Figure 43. Brazil Blocking Peptides Revenue Growth 2016-2021 ($ Millions)
Figure 44. APAC Blocking Peptides Sales Market Share by Region in 2020
Figure 45. APAC Blocking Peptides Revenue Market Share by Regions in 2020
Figure 46. APAC Blocking Peptides Sales Market Share by Type in 2020
Figure 47. APAC Blocking Peptides Sales Market Share by Application in 2020
Figure 48. China Blocking Peptides Revenue Growth 2016-2021 ($ Millions)
Figure 49. Japan Blocking Peptides Revenue Growth 2016-2021 ($ Millions)
Figure 50. Korea Blocking Peptides Revenue Growth 2016-2021 ($ Millions)
Figure 51. Southeast Asia Blocking Peptides Revenue Growth 2016-2021 ($ Millions)
Figure 52. India Blocking Peptides Revenue Growth 2016-2021 ($ Millions)
Figure 53. Australia Blocking Peptides Revenue Growth 2016-2021 ($ Millions)
Figure 54. Europe Blocking Peptides Sales Market Share by Country in 2020
Figure 55. Europe Blocking Peptides Revenue Market Share by Country in 2020
Figure 56. Europe Blocking Peptides Sales Market Share by Type in 2020
Figure 57. Europe Blocking Peptides Sales Market Share by Application in 2020
Figure 58. Germany Blocking Peptides Revenue Growth 2016-2021 ($ Millions)
Figure 59. France Blocking Peptides Revenue Growth 2016-2021 ($ Millions)
Figure 60. UK Blocking Peptides Revenue Growth 2016-2021 ($ Millions)
Figure 61. Italy Blocking Peptides Revenue Growth 2016-2021 ($ Millions)
Figure 62. Russia Blocking Peptides Revenue Growth 2016-2021 ($ Millions)
Figure 63. Middle East & Africa Blocking Peptides Sales Market Share by Country in 2020
Figure 64. Middle East & Africa Blocking Peptides Revenue Market Share by Country in 2020
Figure 65. Middle East & Africa Blocking Peptides Sales Market Share by Type in 2020
Figure 66. Middle East & Africa Blocking Peptides Sales Market Share by Application in 2020
Figure 67. Egypt Blocking Peptides Revenue Growth 2016-2021 ($ Millions)
Figure 68. South Africa Blocking Peptides Revenue Growth 2016-2021 ($ Millions)
Figure 69. Israel Blocking Peptides Revenue Growth 2016-2021 ($ Millions)
Figure 70. Turkey Blocking Peptides Revenue Growth 2016-2021 ($ Millions)
Figure 71. GCC Country Blocking Peptides Revenue Growth 2016-2021 ($ Millions)
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles

※본 조사보고서 [세계의 블로킹 펩타이드 시장예측 2021년-2026년] (코드 : LPI-2108K202167) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 블로킹 펩타이드 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 표식 펩타이드 시장예측 2021년-2026년
LPI-2108K200070 / LP Information / 2021년 8월 / 본 조사보고서는 표식 펩타이드의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Labeled Peptides will have significant change from previous year. By the most conservative estimates of global Labeled Peptides market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...

세계의 차단 밸브 시장예측 2021년-2026년
LPI-2108K202415 / LP Information / 2021년 8월 / 본 조사보고서는 차단 밸브의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Blocking Valves will have significant change from previous year. By the most conservative estimates of global Blocking Valves market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...

세계의 트레오닌 산 시장예측 2021년-2026년
LPI-2108K201911 / LP Information / 2021년 8월 / 본 조사보고서는 트레오닌 산의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Threonine Acid will have significant change from previous year. By the most conservative estimates of global Threonine Acid market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over...

세계의 GnRH 수용체 길항제 시장예측 2021년-2026년
LPI-2108K201409 / LP Information / 2021년 8월 / 본 조사보고서는 GnRH 수용체 길항제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of GnRH Receptor Antagonists will have significant change from previous year. By the most conservative estimates of global GnRH Receptor Antagonists market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 여드름 치료제 시장예측 2021년-2026년
LPI-2108K202092 / LP Information / 2021년 8월 / 본 조사보고서는 여드름 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Acne Medication will have significant change from previous year. By the most conservative estimates of global Acne Medication market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 6748.3 million in 2019. Over...